News

WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
News-Medical.Net15h
WHO and UNICEF urge action to protect children through vaccines
In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis ...